Quick Comparison
| Emoxypine (Mexidol) | Zinc | |
|---|---|---|
| Half-Life | 2-2.6 hours | Tissue zinc turns over over weeks |
| Typical Dosage | Standard: 125-375 mg daily in 2-3 divided doses. Commonly 125 mg twice daily. Take with food. Effects are noticeable within 30-60 minutes. Russian clinical practice uses 4-6 week courses. | Standard: 15-30 mg elemental zinc daily. Do not exceed 40 mg daily long-term (can cause copper depletion). Zinc picolinate, zinc bisglycinate, and zinc carnosine are well-absorbed forms. Zinc oxide is poorly absorbed. Take with food to reduce nausea. If supplementing >15 mg daily, add 1-2 mg copper. |
| Administration | Oral (tablets). Also available as IV/IM injection in clinical settings. Mexidol is the brand name. | Oral (capsules, tablets, lozenges). Take with food. Zinc picolinate or bisglycinate for best absorption. |
| Research Papers | 10 papers | 9 papers |
| Categories |
Mechanism of Action
Emoxypine (Mexidol)
Emoxypine (2-ethyl-6-methyl-3-hydroxypyridine succinate) has a 3-hydroxypyridine structure similar to vitamin B6 (pyridoxine). It is one of the most potent inhibitors of lipid peroxidation in brain tissue — it scavenges hydroxyl radicals and peroxyl radicals, inhibits Fe2+-induced lipid peroxidation, and may chelate transition metals. It modulates the GABA-benzodiazepine receptor complex (GABA-A), enhancing GABAergic transmission through positive allosteric modulation — possibly at a site distinct from the classical benzodiazepine binding site, explaining the lack of sedation and tolerance. It improves mitochondrial function (Complex I protection, membrane stabilization), stabilizes cell membranes (reducing fluidity changes during oxidative stress), and enhances cerebral microcirculation (possibly via nitric oxide or prostaglandin modulation). The anxiolytic mechanism may involve partial agonism or different subunit selectivity.
Zinc
Zinc is released from synaptic vesicles (via ZnT3 transporter) during neurotransmission from glutamatergic mossy fiber and Schaffer collateral terminals. It modulates NMDA receptors — at high concentrations zinc blocks the channel at a distinct site from Mg2+, while at low concentrations it potentiates via the GluN2A subunit. Zinc modulates GABA-A receptors (positive allosteric at alpha1, negative at alpha2/3) and glycine receptors. It is required for BDNF synthesis (zinc finger transcription factors) and TrkB signaling. Zinc-dependent enzymes include carbonic anhydrase (CAII, pH regulation), Cu/Zn superoxide dismutase (SOD1, antioxidant defense), and matrix metalloproteinases (synaptic remodeling). In the hippocampus, zinc modulates long-term potentiation (LTP) via CaMKII and MAPK/ERK pathways — the cellular basis of memory formation. Zinc also regulates presynaptic vesicle release.
Risks & Safety
Emoxypine (Mexidol)
Common
Mild nausea, drowsiness, dry mouth.
Serious
Limited Western safety data. Allergic reactions reported.
Rare
Elevated blood pressure, emotional lability.
Zinc
Common
Nausea on empty stomach, metallic taste.
Serious
Long-term high-dose use (>40 mg daily) depletes copper, causing anemia and neurological problems.
Rare
Headache, diarrhea, reduced immune function (paradoxically) at very high doses.
Full Profiles
Emoxypine (Mexidol) →
A vitamin B6 derivative with powerful antioxidant and anxiolytic properties, widely prescribed in Russia and Eastern Europe for anxiety, cognitive impairment, and cerebrovascular disease. Emoxypine inhibits lipid peroxidation, modulates GABA-A and benzodiazepine binding sites, and improves cerebral blood flow. It provides anxiolytic effects similar to benzodiazepines without sedation, tolerance, or addiction.
Zinc →
An essential trace mineral concentrated in the brain's hippocampus, where it plays a critical role in synaptic transmission and memory formation. Zinc modulates NMDA and GABA receptors, supports BDNF expression, and is required for proper neurotransmitter release. Deficiency is common (estimated 17-25% of the global population) and directly impairs memory, attention, and mood.